Research ArticleFragile X Syndrome

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

See allHide authors and affiliations

Science Translational Medicine  13 Jan 2016:
Vol. 8, Issue 321, pp. 321ra5
DOI: 10.1126/scitranslmed.aab4109

Log in to view PDF

Log in through your institution

Log in through your institution